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Abstract. 
 
Insulin stimulates adipose cells both to se-
crete proteins and to translocate the GLUT4 glucose 
transporter from an intracellular compartment to the 
plasma membrane. We demonstrate that whereas insu-
lin stimulation of 3T3-L1 adipocytes has no effect on 
 
secretion of the 
 
a
 
3 chain of type VI collagen, secretion 
of the protein hormone adipocyte complement related 
protein of 30 kD
 
 
 
(ACRP30) is markedly enhanced. 
Like GLUT4, regulated exocytosis of ACRP30 appears 
to require phosphatidylinositol-3-kinase activity, since 
insulin-stimulated ACRP30 secretion is blocked by 
pharmacologic inhibitors of this enzyme. Thus, 3T3-L1 
adipocytes possess a regulated secretory compartment 
containing ACRP30. Whether GLUT4 recycles to such 
a compartment has been controversial. We present de-
convolution immunoﬂuorescence microscopy data 
demonstrating that the subcellular distributions of 
ACRP30 and GLUT4 are distinct and nonoverlapping; 
in contrast, those of GLUT4 and the transferrin recep-
tor overlap. Together with supporting evidence that 
GLUT4 does not recycle to a secretory compartment 
via the trans-Golgi network, we conclude that there are 
at least two compartments that undergo insulin-stimu-
lated exocytosis in 3T3-L1 adipocytes: one for ACRP30 
secretion and one for GLUT4 translocation.
Key words: exocytosis • monosaccharide transport 
proteins • insulin • adipose tissue • secretion
 
A
 
DIPOCYTES
 
 function as endocrine cells, and are the
exclusive source of several serum proteins includ-
ing leptin, adipsin (equivalent to complement fac-
tor D), and adipocyte complement related protein of 30
 
kD (ACRP30)
 
1
 
 (also called adipoQ) (Kitagawa et al., 1989;
Zhang et al., 1994; Scherer et al., 1995; Hu et al., 1996). Of
these, leptin has received the most attention because of its
clear role in regulating body weight. ACRP30 likely also
plays an important role in energy homeostasis, since it is
dysregulated in obesity and has close structural homology
to TNF-
 
a
 
, another protein secreted by adipocytes and im-
plicated in insulin resistance (Hu et al., 1996; Uysal et al.,
1997; Shapiro and Scherer, 1998). Secretion of ACRP30
from 3T3-L1 adipocytes, like that of adipsin and leptin,
is enhanced by insulin stimulation (Kitagawa et al., 1989;
Scherer et al., 1995; Barr et al., 1997; Bradley and Cheat-
ham, 1999). Importantly, it has not been determined
whether this effect of insulin is mediated by a regulated
secretory compartment, or if insulin instead nonspecifi-
cally accelerates the entire secretory pathway. In the case
of leptin, insulin appears to acutely stimulate export from
the endoplasmic reticulum (ER) of isolated rat adipocytes
(Barr et al., 1997). Yet, whether this effect is solely respon-
sible for the insulin-mediated enhancement of leptin se-
cretion remains unknown.
Insulin also regulates intracellular trafficking of the
GLUT4 glucose transporter in adipose and muscle. This
regulation is of central importance in glucose homeostasis,
since it is primarily the presence of GLUT4 in the plasma
membrane that determines glucose utilization in these tis-
sues (Kahn, 1996; Stenbit et al., 1997). Upon binding of in-
sulin to its receptor, the rate of GLUT4 exocytosis in-
creases with little or no decrease in the rate of GLUT4
endocytosis, resulting in a net shift in the subcellular distri-
bution of GLUT4 to the plasma membrane (Satoh et al.,
1993; Yang and Holman, 1993). Once in the plasma mem-
brane, GLUT4 facilitates diffusion of glucose into the cell,
resulting in a 20–30-fold increase in the rate of glucose
 
uptake in the presence of insulin. The effect of insulin
on GLUT4 trafficking is mediated, at least in part, by
phosphatidylinositol-3-kinase (PI-3 kinase), but the down-
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stream effectors of this enzyme, as well as the subcellular
compartment(s) that are mobilized, are poorly defined
(Rea and James, 1997; Jiang et al., 1998).
Several investigators have attempted to determine
whether or not the insulin-stimulatable GLUT4 compart-
ment is part of a regulated pathway for protein secretion:
is the compartment more analogous to endosomally de-
rived synaptic vesicles, or to biosynthetically derived se-
cretory vesicles? The latter possibility is consistent with
the finding that GLUT4 is present in the trans-Golgi net-
work (TGN), the site where most secretory vesicles form,
and that it is depleted from this compartment after insulin
stimulation (Slot et al., 1991; Rindler, 1992). Indeed, when
exogenously expressed in differentiated PC12 neuroendo-
crine cells, GLUT4 was concentrated in large dense core
vesicles, characteristic of a specialized secretory compart-
ment, as well as in early and late endosomes (Hudson et al.,
1993). In contrast, other investigators working with the
same cell type found that exogenously expressed GLUT4
was targeted to small vesicles, distinct from both large
dense core vesicles and small synaptic vesicles, as exam-
ined by both subcellular fractionation and electron micros-
copy (Herman et al., 1994). This compartment was mobi-
lized by insulin stimulation and appeared to be present in
several cell types, suggesting that it is not part of a special-
ized secretory pathway. Similar results were found in in-
sulinoma cells, where exogenously expressed GLUT4 was
targeted to vesicles distinct from both insulin-containing
secretory granules and synaptic-like vesicles (Thorens and
Roth, 1996).
In the above studies, the GLUT4 cDNA was transfected
into insulinoma cells or PC12 neuroendocrine cells, chosen
because they have well-characterized pathways for regu-
lated secretion or for synaptic vesicle recycling. Because
targeting may have been affected either by overexpression
of GLUT4 protein or by expression in a non-native cell
type, Slot et al. (1997) examined endogenous GLUT4 in
cardiac muscle. Electron microscopy indicated that 50–
60% of endogenous GLUT4 is targeted to secretory gran-
ules in cardiac myocytes, as assessed by costaining for
atrial natriuretic factor, and suggested that a large propor-
tion of GLUT4 enters a regulated secretory pathway at
the TGN. However, insulin stimulation failed to cause de-
monstrable atrial natriuretic factor release, though it sig-
nificantly increased 2-deoxyglucose uptake. Other investi-
gators found that in rat adipocytes, wortmannin blocks
insulin-stimulated GLUT4 trafficking at a step apparently
distal to segregation from late endosomal and TGN mark-
ers, suggesting that GLUT4 does not recycle through these
compartments (Malide and Cushman, 1997). Thus, con-
flicting data have been reported as to whether insulin stim-
ulates GLUT4 exocytosis via a regulated secretory com-
partment, or if GLUT4 recycling occurs independently of
insulin-stimulated protein secretion.
To determine if a regulated secretory compartment
exists in 3T3-L1 adipocytes, we compared secretion of
ACRP30 with that of the 
 
a
 
3 subunit of mouse type VI col-
lagen. Previous work in our laboratory has shown that
ACRP30 is highly enriched in adipose tissue, that its ex-
pression is induced during 3T3-L1 adipocyte differentia-
tion, and that it undergoes basal as well as insulin-stimu-
lated secretion (Scherer et al., 1998). We hypothesized
that if a regulated secretory compartment exists in these
cells, then ACRP30 but not 
 
a
 
3 (VI) collagen might be tar-
geted to this compartment. Consistent with our prediction,
pulse-chase experiments demonstrate that secretion of
ACRP30, but not 
 
a
 
3 (VI) collagen, is enhanced by insulin.
Secretion of ACRP30, but not 
 
a
 
3 (VI) collagen, is also
stimulated by a calcium ionophore (A23187); this effect is
observed late in the chase period and is less dramatic than
that of insulin. We also demonstrate that insulin-stimu-
lated exocytosis of the ACRP30 compartment is likely me-
diated by PI-3 kinase, since inhibitors of this enzyme block
insulin-stimulated, but not basal ACRP30 secretion. Be-
cause much leptin appears to reside in the ER in primary
rat adipocytes (Barr et al., 1997), we costained ACRP30
and GRP94, a resident protein of the ER. We observed
partial colocalization of ACRP30 with this protein; the
proportion of ACRP30 that does not overlap GRP94 is
presumably in a more distal compartment of a regulated
secretory pathway. These data indicate that an insulin-reg-
ulated secretory compartment is present in 3T3-L1 adipo-
cytes, and that ACRP30 but not 
 
a
 
3 (VI) collagen is tar-
geted to this compartment.
We next performed deconvolution immunofluorescence
microscopy to determine if GLUT4 recycles to the reg-
ulated exocytic compartment containing ACRP30. Our
data demonstrate that whereas the subcellular distribu-
tions of GLUT4 and transferrin receptor (TfnR) overlap,
those of ACRP30 and GLUT4 are distinct and nonover-
lapping in both unstimulated and insulin-stimulated cells.
To support our conclusion that GLUT4 does not recycle
to a secretory pathway, we confirm that GLUT4 in the
perinuclear region does not colocalize with a Golgi marker
(
 
b
 
-COP), and is distinct from a TGN marker (
 
g
 
-adaptin),
with no apparent difference between unstimulated and in-
sulin-stimulated cells. We conclude that there are at least
two compartments that undergo insulin-regulated exocy-
tosis in 3T3-L1 adipocytes: one for ACRP30 secretion and
one for GLUT4 translocation.
 
Materials and Methods
 
Antibodies and Reagents
 
A rabbit polyclonal antibody raised against the carboxy terminus of
GLUT4 (MC2A) (Charron et al., 1989) was a gift of Dr. Maureen Char-
ron (Albert Einstein College of Medicine, Bronx, NY). A goat polyclonal
carboxy-terminal GLUT4 antibody was purchased from Santa Cruz Bio-
technology. Rabbit ACRP30 and 
 
a
 
3 (VI) collagen antisera (Scherer et al.,
1995, 1998) were a gift of Dr. Philipp Scherer (Albert Einstein College of
Medicine). A rat TfnR mAb was purchased from PharMingen. Rabbit an-
tiserum to 
 
b
 
-COP and rat anti-GRP94 mAb antibody (clone 9G10) were
from Affinity Bioreagents. A mouse mAb to adaptin-
 
g
 
 was purchased
from Transduction Laboratories. Normal goat and donkey sera and fluo-
rophore-conjugated secondary antibodies cross-adsorbed against the rele-
vant species-specific IgGs were purchased from Jackson ImmunoRe-
search, Inc. Paraformaldehyde (16% solution) was purchased from
Electron Microscopy Sciences.
 
Cell Culture
 
Murine 3T3-L1 fibroblasts were kindly provided by E. Santos (National
Institutes of Health, Bethesda, MD) and were cultured in DME contain-
ing 10% fetal calf serum (Benito et al., 1991). Differentiation was induced
as described (Frost and Lane, 1985). Appropriate differentiation was con-
firmed by noting accumulation of lipid droplets, and cells were used 8–12 d
after induction of differentiation. 
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Pulse-chase Experiments and Immunoprecipitations
 
The protocol used was modified from Scherer et al. (1995). 3T3-L1 adipo-
cytes grown and differentiated in 10-cm tissue culture dishes were starved
in DME for a total of at least 3 h. During the final hour of serum starva-
tion, the medium was changed to DME lacking cysteine and methionine
(ICN Radiochemicals). For some experiments, 100 nM wortmannin
(Sigma Chemical Co.), 10 
 
m
 
M LY294002 (Calbiochem), or 10 ng/ml rapa-
mycin (Calbiochem) was added during the last 45 min of starvation. Cells
were then pulse-labeled for 15 min in the same medium supplemented
with 0.5–0.7 mCi/ml Express Protein Labeling reagent, a mixture of 
 
35
 
S-
labeled cysteine and methionine (1,000 Ci/mmol; DuPont/New England
Nuclear). Cells were then washed twice with DME containing unlabeled
cysteine and methionine, and then incubated during a 2-h chase period at
37
 
8
 
C in DME containing 300 
 
m
 
M cycloheximide to prevent further protein
synthesis, with or without 160 nM insulin or 200 
 
m
 
M A23187 (Calbio-
chem). Cells that were pretreated with wortmannin, LY294002, or rapa-
mycin were maintained in the presence of these drugs during the chase pe-
riod. At 30-min intervals, the medium was collected from each plate and
was replaced with identical fresh medium. Samples were kept on ice until
all were collected, then insoluble debris was removed by centrifugation
(15,000 
 
g
 
, 10 min, 4
 
8
 
C). Samples were precleared by incubation with 60 
 
m
 
l
protein A–Sepharose for 30–60 min at 4
 
8
 
C. Immunoprecipitations each
used 6 
 
m
 
l of antisera directed against ACRP30 or 
 
a
 
3 (VI) collagen, and
were allowed to proceed for a minimum of 4 h at 4
 
8
 
C, after which 100 
 
m
 
l
protein A–Sepharose was added and the incubations were continued for
an additional 45 min. ACRP30 and 
 
a
 
3 (VI) collagen were immunoprecip-
itated sequentially from the same samples. Immunoprecipitates were
washed five times in TNET (1% Triton X-100, 150 mM NaCl, 20 mM Tris,
pH 8.0, 2 mM EDTA), electrophoresed on SDS-PAGE, and the dried gels
were fixed, treated with sodium salicylate or Enhance (Amersham), ex-
posed, and quantified using a Fuji PhosphorImager. Experiments were
performed at least twice, with similar results each time.
 
Immunofluorescence Microscopy
 
3T3-L1 adipocytes were reseeded 1 d before fixation to either coverslips
or to the wells of teflon-coated microscope slides (Cel-Line Associates,
Inc.). Cells were serum starved in DME for a minimum of 3 h, then stimu-
lated or not with 160 nM insulin for 12 min. Cells were washed with cold
PBS containing 0.9 mM Ca
 
11
 
 and 0.5 mM Mg
 
11
 
 (PBS
 
11
 
). Fixation was
with 3–4% paraformaldehyde in PBS for 45 min at room temperature, fol-
lowed by permeabilization with 0.2% Triton X-100 in PBS
 
11
 
 at 4
 
8
 
C. In
some instances, cells were washed with PBS
 
11
 
 and stored before staining
at 4
 
8
 
C in PBS
 
11
 
, 2% BSA, and sodium azide. After washing the cells
again with PBS
 
11
 
, nonspecific antibody binding was blocked with
PBS
 
11
 
 containing 2% BSA and 4% goat or donkey serum (blocking
buffer), as appropriate to the source of the secondary antibody, for 30
min. In experiments using the goat GLUT4 antisera, only donkey second-
ary antibodies were used. Primary antibodies were used at dilutions rang-
ing from 1:200 to 1:500 in blocking buffer. Incubation with primary anti-
bodies was for 60–120 min at 25
 
8
 
C or 37
 
8
 
C in a humidified chamber. The
cells were again washed with PBS
 
11
 
, and then incubated with FITC- or
Cy3-conjugated goat or donkey secondary antibodies at dilutions of 1:200
to 1:400 in blocking buffer. Incubation with secondary antibodies was for
30–45 min at 25
 
8
 
C or 37
 
8
 
C in a humidified chamber. The cells were rinsed
twice with PBS
 
11
 
 and then washed at least three times, for 10 min each,
with PBS
 
11
 
. Coverslips were mounted using Vectashield (Vector Labo-
ratories). For all microscopy experiments, controls were done to demon-
strate that the binding of secondary antibodies was specific for the in-
tended primary antibody. Additionally, the specificity of the rabbit
ACRP30 and rabbit and goat GLUT4 antisera was shown in peptide com-
petition experiments (data not shown).
Deconvolution microscopy was performed using a CELLscan system
by Scanalytics, Inc., attached to either an Olympus or a Nikon Eclipse
E-800 microscope. Both microscopes were equipped with an excitation filter
wheel and a triple bandpass cube containing a dichroic mirror and emis-
sion filter, ensuring registration of two or three color images in both the
X–Y plane and along the Z-axis. Empirical point spread functions were
obtained immediately before image acquisition by using 0.1-
 
m
 
m diam la-
tex beads fluorescent at the appropriate wavelengths (Molecular Probes).
Beads were diluted in PBS and briefly sonicated to disrupt aggregates,
and were then by mounted on microscope slides using Vectashield under
conditions identical to those for 3T3-L1 cells. For both point spread func-
tion and image acquisition, through-focusing was done using the 100
 
3
 
/1.4
NA objective and acquiring data at 250-nm intervals. For cross-sectional
 
images of cells, at least nine planes of raw image data were obtained so as
to optimize reconstruction of the center plane image. Deconvolution was
done on a CSPI high speed processor, and both raw and reconstructed im-
ages were acquired with 12-bit/pixel resolution. Under these conditions,
we estimate lateral resolution at 180 nm. Images were pseudocolored and
merged using Photoshop (Adobe Systems, Inc.); final pixel depth is 8 bits/
channel.
 
Results
 
Insulin Stimulates Secretion of ACRP30, But Not
 
a
 
3 (VI) Collagen
 
To determine if the insulin-stimulated enhancement of
ACRP30 secretion is mediated by a regulated secretory
compartment, or if it represents a nonspecific acceleration
of the entire secretory pathway, we compared secretion of
ACRP30 and 
 
a
 
3 (VI) collagen in a pulse-chase experi-
ment. Previous work done in our laboratory using a com-
plex antisera raised against many proteins secreted from
3T3-L1 adipocytes demonstrated that insulin enhances se-
cretion of some, but not all, of these proteins (Scherer et
al., 1998; Scherer, P.E., and H.F. Lodish, unpublished re-
sults). We hypothesized that one specific protein that does
not participate in an insulin-regulated secretory compart-
ment might be 
 
a
 
3 (VI) collagen (Scherer et al., 1998). Ac-
cordingly, we followed secretion into the media of a dis-
crete population of newly synthesized protein, synthesized
during a short pulse of labeled amino acids and chased in
the presence of cycloheximide and in the presence or ab-
sence of insulin or a calcium ionophore, A23187. The
media were collected at intervals throughout the chase
period, and 
 
a
 
3 (VI) collagen and ACRP30 were immuno-
precipitated sequentially from the same samples. Fig. 1 A
shows a representative experiment; in Fig. 1 B these data
are used to plot the cumulative amount of each protein se-
creted. Whereas insulin clearly enhances ACRP30 secre-
tion, there is no effect on 
 
a
 
3 (VI) collagen secretion. The
insulin-stimulated increase in ACRP30 secretion is most
marked during the early part of the chase period, consis-
tent with an effect of insulin to accelerate the early part of
the secretory pathway. Yet, insulin’s effect may not be lim-
ited to this part of the secretory pathway, since ACRP30
secretion is increased even at later time points. A23187 has
a minimal effect early in the chase period, but enhances
ACRP30 secretion, and not 
 
a
 
3 (VI) collagen secretion, af-
ter 90 min. This result is consistent with an effect late in
the secretory pathway, involving a compartment to which
ACRP30, but not 
 
a
 
3 (VI) collagen, is targeted. Thus, the
data indicate that the insulin-stimulated enhancement of
ACRP30 secretion is not due to nonspecific acceleration
of the entire secretory pathway. Rather, ACRP30 is tar-
geted to a regulated secretory compartment in 3T3-L1 adi-
pocytes, and 
 
a
 
3 (VI) collagen is excluded from this com-
partment.
 
Inhibitors of PI-3 Kinase Block Insulin-stimulated, But 
Not Basal, ACRP30 Secretion
 
PI-3 kinase activity is stimulated by insulin, and has been
implicated in the insulin signal transduction pathway lead-
ing to GLUT4 exocytosis. To determine if PI-3 kinase acti-
vation is also required for insulin-stimulated ACRP30 se-
cretion, we performed pulse-chase experiments similar to 
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those described in Fig. 1, but in the presence or absence of
two pharmacologic inhibitors of PI-3 kinase, wortmannin
and LY294002. Fig. 2 plots cumulative ACRP30 secretion,
and demonstrates that ACRP30 secretion is enhanced by
insulin in cells left untreated or in the presence of rapamy-
cin, used here as a negative control, and that this effect is
absent in the presence of wortmannin or LY294002. Like
the results shown in Fig. 1, the increased secretion is espe-
cially marked during the first 30 min of the chase period in
the untreated and rapamycin-treated cells. In the presence
of wortmannin, ACRP30 secretion at the 30-min time
point is not significantly enhanced by insulin, and at subse-
quent time points the cumulative secretion in the presence
of insulin is even less than in the absence of insulin. Simi-
larly, LY294002 completely abolishes the effect of insulin,
so that cumulative ACRP30 secretion is essentially identi-
cal in the presence or absence of insulin in cells treated
with this drug. No definite effect is seen on basal ACRP30
secretion under any of the conditions tested. Thus, PI-3 ki-
nase inhibitors specifically block insulin-stimulated exocy-
tosis of ACRP30. Together with the data presented in Fig.
1, we conclude that ACRP30 is targeted to a regulated
secretory compartment, the exocytosis of which is stimu-
lated by insulin through a PI-3 kinase activity.
 
ACRP30 Immunostaining Partially Overlaps with That 
of GRP94, a Resident of the ER
 
It has been reported that leptin largely colocalizes with
calnexin, a marker for the ER, in isolated rat adipocytes
(Barr et al., 1997). To determine whether this is also true
of ACRP30 in 3T3-L1 adipocytes, we used deconvolution
immunofluorescence microscopy to obtain cross-sectional
images of cells stained for ACRP30 and GRP94. GRP94
(also called endoplasmin) is a well-characterized lumenal
protein of the ER that contains a carboxy-terminal KDEL
motif, and that functions in concert with GRP78/BiP to as-
sist in protein folding (Koch et al., 1986; Gething and Sam-
brook, 1992; Melnick et al., 1992, 1994). As shown in Fig.
3, some but not all ACRP30 staining overlaps with that of
GRP94. GRP94 staining (shown in red) is reticular with
some pronounced punctae, and is present throughout the
cytoplasm in both unstimulated (Fig. 3 a) and insulin-stim-
ulated (Fig. 3 d) cells. ACRP30 staining (Fig. 3, b and e,
green) is mostly punctate, but has a reticular component as
well. In unstimulated cells, there is moderate overlap of
these two proteins (Fig. 3 c, yellow), though it is also clear
that some ACRP30 staining does not overlap with GRP94
staining (Fig. 3 c, green). ACRP30 expression was hetero-
geneous, in that it was commonly observed that not all
cells that had differentiated by morphological criteria (as
assessed by the presence of lipid droplets) stained for
ACRP30 on immunofluorescence microscopy. The staining
for GRP94 (red), but not ACRP30, present in the lower
left quadrant of Fig. 3 c represents an adjacent cell not ex-
pressing ACRP30; there is very little staining for GRP94
by itself (i.e., not overlapping ACRP30) in the remainder
of the image. In comparison to unstimulated cells, insulin-
Figure 1. Insulin stimulates ACRP30 secretion
from 3T3-L1 adipocytes, but does not stimulate a3
(VI) collagen secretion. Three 10-cm plates of
3T3-L1 adipocytes were serum-starved and total
cellular protein was labeled with a 15-min pulse of
35S-labeled cysteine and methionine. Cells were
washed and then chased in serum-free media con-
taining cycloheximide to inhibit further protein
synthesis. Additionally during the chase period,
cells were maintained in the presence or absence
of 160 nM insulin or 200 mM A23187. The media
were collected and replaced at 30-min intervals,
and the appearance of labeled ACRP30 or a3
(VI) collagen in the media was assessed by se-
quential immunoprecipitations. The immunopre-
cipitates were analyzed SDS-PAGE, and bands
were detected and quantified using a Phosphor-
Imager. A shows the bands corresponding to
ACRP30 and a3 (VI) collagen for each condition.
In B, these bands were quantified and the cumula-
tive secretion into the media is plotted for each
protein. The total amount of protein secreted by
unstimulated cells is taken as 100% and all other
data are plotted relative to this amount. 
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stimulated cells have more prominent staining for GRP94
that does not overlap with ACRP30 (Fig. 3 f, red), though
some overlap also remains (yellow). These findings are
subtle, but are observed consistently in the highest quality
images. Thus, the data suggest that insulin stimulates
movement of ACRP30 out of the ER. More significantly,
a proportion of ACRP30 does not overlap with GRP94,
and is presumably in a more distal compartment of a regu-
lated secretory pathway.
 
GLUT4 and ACRP30 Do Not Colocalize within
3T3-L1 Adipocytes
 
To determine if GLUT4 recycles to the insulin-regulated
secretory pathway containing ACRP30, we employed de-
convolution immunofluorescence microscopy to obtain
cross-sectional images of GLUT4 and ACRP30 in 3T3-L1
adipocytes. Fig. 4 presents representative images of adipo-
cytes stained for GLUT4 (shown in red) and ACRP30
(shown in green). The staining for GLUT4 is punctate,
Figure 2. PI-3 kinase inhibitors block insulin-
stimulated, but not basal, ACRP30 secretion.
Eight 10-cm plates of 3T3-L1 adipocytes were se-
rum-starved and then treated or not with wort-
mannin, LY294002, or rapamycin at the indi-
cated concentrations for 45 min. As in Fig. 1,
total cellular protein was labeled with a 15-min
pulse of 35S-labeled cysteine and methionine, fol-
lowed by inhibition of further protein synthesis
with cycloheximide. During the chase period,
cells were maintained in the presence or absence
of 160 nM insulin and the continued presence or
absence of inhibitors, and the medium was col-
lected and replaced at 30-min intervals. ACRP30
was quantitatively immunoprecipitated from the
media collected at each time point. The immuno-
precipitates were separated by SDS-PAGE and
the amount of ACRP30 present at each data
point was quantified using a PhosphorImager.
Cumulative ACRP30 is plotted for cells chased
in the absence (open squares) or presence (filled
diamonds) of insulin. The total amount of pro-
tein secreted by the untreated cells in the pres-
ence of insulin is taken as 100%; all other data
are plotted relative to this amount.
Figure 3. ACRP30 and GRP94
staining partially overlap. 3T3-
L1 adipocytes were costained
for ACRP30 (shown in green)
and GRP94 (shown in red), and
optical cross-sections were ac-
quired by deconvolution immu-
nofluorescence microscopy. To
demonstrate a large amount of
staining for both proteins, the
images presented are merged
stacks of nine optical cross-sec-
tions spanning a total of 2.25
mm perpendicular to the image
plane; a similar degree of over-
lap was observed in individual
cross-sections. GRP94 staining
is shown in a and d; ACRP30
staining is shown in b and e.
Merged images are shown in c
and f. a–c show staining of un-
stimulated 3T3-L1 adipocytes,
and d–f show staining of insulin-
stimulated 3T3-L1 adipocytes.
Bar, 10 mm. 
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consistent with a vesicular compartment, with prominent
perinuclear staining that is in a more tubulovesicular pat-
tern (Fig. 4, a, d, and g). This distribution has been noted
previously by others, and is characteristic of GLUT4
(Piper et al., 1991; Smith et al., 1991). ACRP30 staining,
too, is mainly punctate, but also has a reticular component
and is present more equally throughout the cytoplasm,
with less perinuclear accumulation (Fig. 4, b, e, and h).
The merged images (Fig. 4, c, f, and i) demonstrate that
there is essentially no overlap (yellow) in the subcellular
distribution of the two proteins. This is the case for both
unstimulated and insulin-stimulated cells (Fig. 4, a–f and
g–i, respectively). Indeed, because the staining for these
two proteins is so distinct, we have presented views
through several cross-sections in Fig. 4 and still see no sig-
nificant overlap. Insulin stimulation (160 nM, 12 min) of
cells before fixation clearly results in accumulation of
GLUT4 at the plasma membrane (Fig. 4 g, arrowheads),
but did not cause any obvious change in the pattern of
ACRP30 staining. Thus, GLUT4 does not appear to par-
ticipate in the regulated secretory compartment that con-
tains ACRP30.
 
TfnR Immunostaining Significantly Overlaps with That 
of GLUT4, But Not ACRP30
 
Fig. 5 shows immunofluorescence images of cells stained
with GLUT4 (in red) and TfnR (in green). Both GLUT4
(Fig. 5, a and d) and TfnR (Fig. 5, b and e) are present in
a punctate pattern at the periphery of the cell and in a
Figure 4. ACRP30 and GLUT4
do not colocalize in 3T3-L1 adi-
pocytes. Immunofluorescence
of GLUT4 (red) and ACRP30
(green) was performed on 3T3-L1
adipocytes, and optical cross-
sections were acquired by de-
convolution microscopy. The
images presented are views
through nine optical cross-sec-
tions. GLUT4 staining is shown
in a, d, and g; ACRP30 staining
is shown in b, e, and h. Merged
images are shown in c, f, and i.
a–f show staining of unstimu-
lated cells, and g–i show staining
of insulin-stimulated cells. Ar-
rowheads highlight increased
plasma membrane localization
of GLUT4 in cells stimulated
with insulin. n, nucleus. f, lipid.
Bar, 10 mm. 
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more tubulovesicular pattern adjacent to the nucleus. The
merged images (Fig. 5, c and f) demonstrate that there is
significant colocalization (yellow) of the two proteins, with
perhaps half of each colocalizing with the other. This colo-
calization is present in the periphery of the cell as well as
in the perinuclear region. In cells stimulated with insulin
(Fig. 5, d–f), there is more prominent staining of both
GLUT4 and TfnR at the plasma membrane (arrowheads,
Fig. 5, d and e). Of note, neither the perinuclear GLUT4
nor the peripheral GLUT4 overlaps completely with TfnR.
After insulin stimulation, prominent GLUT4 staining re-
mains in the perinuclear region, whereas TfnR staining is
somewhat less marked (Fig. 5 f). Though this effect of in-
sulin was not seen in all images, it may represent participa-
tion of TfnR, but not GLUT4, in a perinuclear recycling
endosome.
As an additional control experiment, we stained cells for
TfnR and ACRP30. As shown in Fig. 6, there is essentially
no overlap in the distribution of these two proteins.
ACRP30 (in red) is once again seen to have punctate and
Figure 5. GLUT4 and TfnR
overlap. Immunofluorescence
of GLUT4 (red) and TfnR
(green) was performed on 3T3-
L1 adipoctes. As in Fig. 4, each
image is a merged composite
of nine adjacent optical cross-
sections; a similar degree of
overlap was seen in individual
cross-sectional images. GLUT4
staining is shown in a and d;
TfnR staining is shown in b and
e. Merged images are shown in
c and f. a–c show staining of un-
stimulated cells, and d–f show
staining of insulin-stimulated
cells. Arrowheads highlight in-
creased plasma membrane lo-
calization of both GLUT4 and
TfnR after insulin stimulation.
Bar, 10 mm. 
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reticular components in both unstimulated (Fig. 6 a) and
insulin-stimulated (Fig. 6 d) cells. The apparent perinu-
clear staining in Fig. 6 d is due, at least in part, to the pres-
ence of several lipid droplets throughout the periphery of
the cell. TfnR staining (Fig. 6, b and e, green) is present
in a more tubulovesicular pattern. There is some TfnR
present at the plasma membrane after insulin stimulation
(Fig. 6 e), though this is less marked than in Fig. 5. The
merged images demonstrate very little overlap (yellow) in
the subcellular distributions of these proteins, in both
unstimulated and insulin-stimulated cells (Fig. 6, c and f,
respectively), corroborating the data shown in Figs. 4
and 5. We conclude that GLUT4 and TfnR are targeted
to compartments that are distinct from those containing
ACRP30.
 
The Subcellular Distribution of GLUT4 Does Not 
Overlap with That of 
 
b
 
-COP, and Is Mostly Separate 
from That of 
 
g
 
-Adaptin
 
If GLUT4 does not recycle to a regulated secretory com-
partment, then GLUT4 in the perinuclear region likely
does not represent recycling to the Golgi complex or
TGN. We sought to confirm this in 3T3-L1 adipocytes by
microscopy of cells costained for GLUT4 and Golgi mark-
ers. We first used an antibody to detect endogenous
 
b
 
-COP, a component of the nonclathrin COPI vesicle coat
that has been localized previously to the Golgi complex
(Duden et al., 1991). Fig. 7 demonstrates that the distribu-
tions of GLUT4 and 
 
b
 
-COP are closely apposed, but do
not overlap either in unstimulated or in insulin-stimulated
cells. GLUT4 (in red) is present in unstimulated cells (Fig.
7 a) and in insulin-stimulated cells (Fig. 7 d) in its charac-
teristic perinuclear location. Compared with Figs. 4 and 5,
less plasma membrane GLUT4 staining is seen in the insu-
lin-treated cells. This is in part due to cell-to-cell variabil-
 
ity; also, data from only one optical cross-section are
shown because views through several cross-sections re-
sulted in the artifactual appearance of overlap due to
staining of GLUT4 and 
 
b
 
-COP in different planes. 
 
b
 
-COP
staining (in green) is also perinuclear, and is not markedly
different in basal (Fig. 7 b) and in insulin-treated cells (Fig.
7 e). The merged images clearly show that there is essen-
tially no overlap (yellow) in the distributions of GLUT4
and 
 
b
 
-COP staining in either unstimulated (Fig. 7 c) or in
insulin-stimulated (Fig. 7 f) cells.
We next stained cells for GLUT4 and 
 
g
 
-adaptin, a com-
ponent of the AP-1 adaptor complex involved in ADP-
ribosylation factor–dependent budding of clathrin-coated
vesicles from the TGN (Ahle et al., 1988; Robinson, 1990;
Stamnes and Rothman, 1993; Traub et al., 1993; Seaman
et al., 1996). Single optical cross-sections of unstimulated
and insulin-stimulated 3T3-L1 adipocytes are shown in
Fig. 8; whereas there is partial overlap of GLUT4 and
 
g
 
-adaptin staining, the overall impression is that these
compartments are distinct. GLUT4 is shown in red and
can more readily be detected on the plasma membrane of
insulin-stimulated cells (Fig. 8 d, arrowheads) than in un-
stimulated cells (Fig. 8 a). As noted for the other images of
GLUT4 presented above, no qualitative differences are
observed in the perinuclear GLUT4 distribution before
and after insulin stimulation. Similarly, 
 
g
 
-adaptin staining
(in green) is perinuclear and tubulovesicular in nature, and
is not noticeably different in unstimulated (Fig. 8 b) and in
insulin-stimulated (Fig. 8 e) cells. The merged images (Fig.
8, c and f) show very little overlap (yellow); most staining
is exclusively for either GLUT4 or for 
 
g
 
-adaptin. Review
of several images revealed no difference between unstimu-
lated and insulin-stimulated cells in the degree of overlap
(compare Fig. 8, c and f). Thus, whereas the possibility of
GLUT4 recycling to the TGN cannot be excluded, the
perinuclear GLUT4 and 
 
g
 
-adaptin staining patterns are
Figure 6. ACRP30 and TfnR do not colocalize.
Immunofluorescence of 3T3-L1 adipocytes
stained for ACRP30 (red) and TfnR (green).
Each image is the merged stack of nine optical
cross-sections, as in Figs. 4 and 5. ACRP30 stain-
ing is shown in a and d; TfnR staining is shown in
b and e. Merged images are shown in c and f. a–c
show staining of unstimulated 3T3-L1 adipo-
cytes, and d–f show staining of insulin-stimulated
3T3-L1 adipocytes. Bar, 10 mm. 
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clearly not identical, and the data support the notion that
GLUT4 does not rejoin the secretory pathway at the level
of the Golgi complex or TGN.
 
Discussion
 
We have shown that insulin stimulates exocytosis of a reg-
ulated secretory compartment, containing ACRP30, in
3T3-L1 adipocytes. This compartment is distinct from that
containing 
 
a
 
3 (VI) collagen, because insulin has no effect
on secretion of this protein. Therefore, it is not the case
that insulin enhances ACRP30 secretion merely by accel-
erating the entire constitutive secretory pathway. Our ob-
servation that a calcium ionophore also stimulates ACRP30
secretion, and not 
 
a
 
3 (VI) collagen secretion, supports this
inference. Thus, we propose that a portion of ACRP30 is
sorted into regulated secretory vesicles whose exocytosis is
stimulated by insulin, and that the remainder is sorted into
vesicles that undergo constitutive exocytosis. We pro-
pose that the latter population accounts for secretion of
ACRP30 in the absence of insulin, and also contains 
 
a
 
3
(VI) collagen and other proteins whose secretion is not en-
hanced by insulin. Partial sorting of protein hormones into
regulated secretory vesicles has been observed in other
types of cultured cells (Moore et al., 1983; Sambanis et al.,
1991).
We also present immunofluorescence microscopy data
demonstrating that whereas some ACRP30 staining over-
laps with that of GRP94, and is presumably in the ER, ad-
ditional ACRP30 staining does not overlap this marker
Figure 7. Perinuclear GLUT4 and b-COP
staining do not overlap. Immunofluorescence of
3T3-L1 adipocytes stained for GLUT4 (red) and
b-COP (green) was performed and optical cross-
sections were acquired by deconvolution micros-
copy. The images shown are the center cross-sec-
tions from the reconstructed stack of images.
GLUT4 staining is shown in a and d; b-COP
staining is shown in b and e. Merged images are
shown in c and f. a–c show staining of unstimu-
lated 3T3-L1 adipocytes, and d–f show staining
of insulin-stimulated 3T3-L1 adipocytes. Bar,
10  mm.
Figure 8. Perinuclear GLUT4 and g-adaptin
staining are mostly separate. 3T3-L1 adipocytes
were stained for GLUT4 (red) and g-adaptin
(green) before deconvolution microscopy. The
images shown are the center cross-sections from
the deconvolved set of images. GLUT4 staining
is shown in a and d; g-adaptin staining is shown
in b and e. Merged images are shown in c and f.
a–c show staining of unstimulated 3T3-L1 adipo-
cytes, and d–f show staining of insulin-stimu-
lated 3T3-L1 adipocytes. Arrowheads indicate
plasma membrane localization of GLUT4 in
cells treated with insulin. Bar, 10 mm. 
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and likely represents protein in peripheral storage vesicles.
Insulin apparently accelerates movement of ACRP30 out
of the ER, because staining for GRP94 that did not over-
lap with ACRP30 was only observed in cells that had been
stimulated with insulin before fixation. Stimulation of
ACRP30 export from the ER may account for observation
that the insulin-stimulated enhancement of ACRP30 se-
cretion is most marked in the early part of the chase pe-
riod. Such export would have to be selective, since insulin
did not increase a3 (VI) collagen secretion. Yet, this may
not be the only site of insulin action: our observation
that insulin also increases ACRP30 secretion late in the
chase period, combined with our immunofluorescence
data showing that some ACRP30 is in peripheral vesicles,
suggests that it mobilizes a pool of regulated secretory ves-
icles in the periphery.
Our proposal that insulin stimulates exocytosis of regu-
lated secretory vesicles is in contrast to that of Barr et al.
(1997), who found no light microscopic evidence that lep-
tin is targeted to such vesicles in rat adipose cells. These
investigators found that the vast majority of leptin staining
coincided with a marker for the ER, and that insulin stim-
ulated export from this compartment. In this respect, our
data that insulin stimulates ACRP30 export from the ER
result is similar. It is possible that the presence of a small
proportion of leptin in regulated vesicles in the periphery
could have gone undetected by Barr et al. (1997), espe-
cially given the morphological challenge presented by pri-
mary adipocytes. Moreover, whereas insulin accelerates
secretion of leptin and adipsin as well as ACRP30, it is not
known if all of these proteins share a common exocytic
pathway (Kitagawa et al., 1989; Scherer et al., 1995; Barr
et al., 1997; Bradley and Cheatham, 1999). Finally, these
different interpretations may reflect actual differences in
the cells used for experiments.
Our work demonstrates that insulin-stimulated en-
hancement of ACRP30 secretion is blocked by pharmaco-
logic PI-3 kinase inhibitors, suggesting that PI-3 kinase ac-
tivation is necessary for insulin stimulation of ACRP30
secretion. PI-3 kinase has been previously implicated in
the insulin signal transduction pathway leading to GLUT4
exocytosis, and treatment of intact fat or muscle cells with
LY294002 or wortmannin blocks insulin-stimulated trans-
location of GLUT4 to the plasma membrane (Cheatham
et al., 1994; Clarke et al., 1994; Le Marchand-Brustel et al.,
1995). Rapamycin, which we used as a negative control,
acts downstream of PI-3 kinase to block insulin-stimulated
p70 S6 kinase activation, but has no effect on glucose
transport in 3T3-L1 adipocytes (Fingar et al., 1993; Monfar
et al., 1995; Weng et al., 1995). Though the specificity of
wortmannin and LY294002 has been questioned (Cross
et al., 1995; Ferby et al., 1996; Balla et al., 1997), recent
work demonstrates that the effect of wortmannin on insu-
lin-stimulated hexose uptake is largely reversed by mem-
brane-permeant esters of phosphatidylinositol-3,4,5-tris-
phosphate, a product of PI-3 kinase activity (Jiang et al.,
1998). Therefore, the notion that PI-3 kinase activation
is necessary for insulin-triggered GLUT4 exocytosis is
supported, and it is through inhibition of this activity
that wortmannin and LY294002 block insulin-stimulated
GLUT4 trafficking. By extension, a strong argument is
made that it is through inhibition of PI-3 kinase activity
that these drugs block the effect of insulin to augment
ACRP30 secretion.
Similar to our results with ACRP30, it has been shown
very recently that the PI-3 kinase inhibitor, LY294002,
blocks insulin-stimulated leptin secretion from rat adipo-
cytes (Bradley and Cheatham, 1999). These investigators
also found that rapamycin decreased insulin-stimulated
leptin secretion, though not as completely as LY294002; in
contrast, we observed no effect of rapamycin on insulin-
stimulated ACRP30 secretion. Aside from the observation
that ACRP30 and leptin may not share a common regu-
lated secretory pathway, this apparent contradiction can
be resolved because our experiments using rapamycin
were done in the presence of cycloheximide, whereas
those of Bradley and Cheatham (1999) were not. Thus, as
pointed out by these authors, it may be the case that the
major effect of rapamycin was to prevent insulin-stimu-
lated mRNA translation.
We have shown that there is no overlap in the subcellu-
lar distributions of GLUT4 and ACRP30 in unstimulated
and in insulin-stimulated 3T3-L1 adipocytes. Together
with our result that ACRP30 participates in a regulated
secretory compartment, we conclude that GLUT4 does
not recycle to a regulated secretory compartment, as de-
fined by ACRP30. Important control experiments demon-
strate that the subcellular distributions of GLUT4 and
TfnR overlap substantially, whereas those of TfnR and
ACRP30 are distinct and nonoverlapping. Further support
that GLUT4 does not recycle to a regulated secretory
pathway are our findings that perinuclear GLUT4 does
not colocalize with a Golgi marker (b-COP) and is mostly
distinct from that of a TGN marker (g-adaptin). Thus,
these parts of the secretory pathway are not major sites to
which GLUT4 is distributed, either in the absence of insu-
lin or after insulin stimulation.
The question of whether GLUT4 recycles to a regulated
secretory pathway, or is instead targeted to synaptic-like
vesicles, has been controversial. Conflicting results may
have been obtained because previous studies relied on ex-
ogenously expressed GLUT4 in cells that do not normally
take up glucose when stimulated by insulin, or were con-
ducted using tissue that does not have a secretory pathway
that is regulated by insulin (Hudson et al., 1993; Herman
et al., 1994; Thorens and Roth, 1996; Slot et al., 1997). We
have addressed these concerns by studying endogenous
GLUT4 in a well established adipose cell culture system,
by showing that ACRP30 participates in a regulated secre-
tory compartment in these cells, and by comparing the
subcellular distributions of ACRP30 and GLUT4. Our
conclusion that GLUT4 does not recycle to a secretory
compartment is similar to that of Malide and Cushman
(1997), who showed that in primary adipocytes wortman-
nin disrupts endocytic trafficking of GLUT4, but has no
effect on trafficking of late endosomal or TGN markers.
Their data suggest that GLUT4 does not recycle through
the late endosome to the Golgi complex. Yet, this conclu-
sion rests on the assumption that if this were the case,
GLUT4 would traffic together with these markers. Addi-
tionally, proteins such as TGN38 recycle from the TGN to
the plasma membrane quite slowly, and relatively short
term wortmannin treatment might not appreciably alter
their distribution (Ghosh et al., 1998). By examining theBogan and Lodish Compartments for Regulated Exocytosis in Adipocytes 619
distribution of GLUT4 relative to a protein that partici-
pates in regulated secretion, we have avoided these poten-
tial pitfalls.
We observed significant overlap in the subcellular distri-
butions of GLUT4 and TfnR. Other investigators have
also noted overlap of GLUT4 and endosomal markers, in-
cluding TfnR, yet contradictory data have been reported
(Tanner and Lienhard, 1989; Hudson et al., 1992; Han-
peter and James, 1995; Ralston and Ploug, 1996; Malide
et al., 1997). The variability in the literature may be ex-
plained, at least in skeletal muscle, by the recent obser-
vation that there are two distinct intracellular GLUT4
compartments: one that cofractionates with the early en-
dosomal markers TfnR and annexin II, and a second com-
partment from which GLUT4 is depleted after insulin
stimulation (Aledo et al., 1997). Likewise in 3T3-L1 adipo-
cytes, experiments involving either immunoisolation of
GLUT4 vesicles or ablation of transferrin (Tfn)–contain-
ing compartments determined the presence of distinct
GLUT4 populations (Livingstone et al., 1996). In both
of these reports, z40% of GLUT4 colocalized with the
TfnR, and z40% of the TfnR colocalized with GLUT4,
consistent with our data as well. Moreover, both reports
suggest that insulin stimulates movement of GLUT4 from
the TfnR-negative pool to the plasma membrane. Al-
though it seems likely that the TfnR-positive GLUT4
compartment is the precursor of the TfnR-negative, insu-
lin-regulated GLUT4 compartment, this has not been
definitively established. Our data add that the TfnR-neg-
ative, insulin-regulated GLUT4 compartment is not iden-
tical to the insulin-regulated compartment for ACRP30
secretion.
We also found that perinuclear GLUT4 does not appear
to rejoin the secretory pathway at the level of the Golgi
complex. GLUT4 immunostaining does not overlap with
that of b-COP, a protein found on the cis side of the Golgi
complex in pancreatic acinar cells and on the lateral rims
and trans face of the Golgi complex in spermatids (Oprins
et al., 1993; Martinez-Menarguez et al., 1996). An addi-
tional pool of b-COP has been described on membranes of
the TGN, though this pool appears not to participate in
budding of transport vesicles (Griffiths et al., 1995). We
also found that GLUT4 immunostaining is mostly sepa-
rate from that of g-adaptin; overall, the data show that the
perinuclear GLUT4 compartment does not correspond to
the TGN. Our interpretation is consistent with previous
light microscopy data that in insulinoma cells, transfected
GLUT4 did not significantly overlap with the TGN
marker protein, TGN38 (Thorens and Roth, 1996). Other
reports have described minimal overlap of GLUT4 and
TGN38 in rat adipose cells, and of GLUT4 and giantin in
cultured myotubes (Ralston and Ploug, 1996; Malide and
Cushman, 1997; Malide et al., 1997). Biochemical studies
of 3T3-L1 adipocytes found that only 5–10% of low den-
sity microsomal GLUT4 was copurified by immunoad-
sorption of vesicles using an antiserum to TGN38; the
copurified GLUT4 did not correspond to the insulin-regu-
lated GLUT4 compartment within the low density mi-
crosomal fraction (Martin et al., 1994). Thus, our data
concerning the perinuclear GLUT4 compartment are in
agreement with other studies noting close association, but
not identity, with the TGN.
In summary, we have shown that ACRP30 participates
in an insulin-regulated secretory compartment in 3T3-L1
adipocytes, and that a3 (VI) collagen does not. Insulin ap-
pears to accelerate ACRP30 secretion at both early and
late steps in its secretory pathway, possibly corresponding
to export of ACRP30 from the ER and to exocytosis of
regulated secretory vesicles containing this protein. Like
GLUT4 exocytosis, insulin-stimulated ACRP30 secretion
is blocked by inhibitors of PI-3 kinase. Finally, we show
that GLUT4 does not recycle to the regulated secretory
pathway containing ACRP30. Insulin-stimulated PI-3 ki-
nase activity must therefore act through effectors present
at multiple locations within the cell.
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